What are Ultrasound contrast agent drugs?

Ultrasound contrast agent drugs are pharmacologic agents that share a common mechanism. 4 are currently marketed, with 8 more in clinical development.

What are the marketed Ultrasound contrast agent drugs?

Marketed Ultrasound contrast agent drugs include Definity infusion, Optison echocardiography contrast agent, Contrast-Enhanced Ultrasound using Lumason, Perflutren lipid.

Ultrasound contrast agent

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

4 marketed 7 in Phase 3 1 in Phase 2

This page covers all Ultrasound contrast agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (4)

Definity infusion · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Cardiology / Diagnostic Imaging
Definity is an ultrasound contrast agent composed of perflutren-filled microbubbles that enhance echocardiographic imaging by increasing ultrasound backscatter from the left ventricular cavity.
Optison echocardiography contrast agent · University of Utah · Cardiovascular
Optison is a microbubble contrast agent that reflects ultrasound waves to enhance echocardiographic imaging of the heart.
Contrast-Enhanced Ultrasound using Lumason · Children's Hospital of Philadelphia · Diagnostic Imaging
Lumason is a microbubble contrast agent that enhances ultrasound imaging by reflecting sound waves, improving visualization of blood flow and tissue perfusion.
Perflutren lipid · UNC Lineberger Comprehensive Cancer Center · Diagnostic Imaging
Perflutren lipid microbubbles enhance ultrasound imaging by providing acoustic contrast through gas-filled lipid shells that reflect ultrasound waves.

Phase 3 pipeline (7)

Sonazoid and Sonovue · Second Affiliated Hospital, School of Medicine, Zhejiang University · Imaging
Sonazoid and Sonovue are ultrasound contrast agents that work by enhancing the contrast of ultrasound images through the use of microbubbles.
Contrast agent: SonoVue®. · Centre Hospitalier Régional Metz-Thionville · Diagnostic Imaging
SonoVue is a microbubble contrast agent that enhances ultrasound imaging by reflecting ultrasound waves, improving visualization of blood flow and tissue perfusion.
AI-700 · Acusphere · Diagnostic Imaging
AI-700 is an ultrasound contrast agent designed to enhance imaging of blood perfusion and tissue characterization.
Sonovue and Sonazoid · Second Affiliated Hospital, School of Medicine, Zhejiang University · Cardiology / Diagnostic Imaging
Sonovue and Sonazoid are ultrasound contrast agents that enhance echocardiographic and ultrasound imaging by producing microbubbles that reflect ultrasound waves.
SonoVue-enhanced ultrasound · Bracco Diagnostics, Inc · Diagnostic Imaging
SonoVue is a microbubble contrast agent that enhances ultrasound imaging by reflecting ultrasound waves, improving visualization of blood flow and tissue perfusion.
SonoVue® · GE Healthcare · Imaging
SonoVue is a microbubble ultrasound contrast agent that enhances ultrasound imaging.
perflutren lipid microspheres · University of Virginia · Cardiovascular
Perflutren lipid microspheres are ultrasound contrast agents that enhance the visibility of blood flow and cardiac function during echocardiography.

Phase 2 pipeline (1)

Definity Suspension for Injection · Sunnybrook Health Sciences Centre · Cardiovascular
Definity Suspension for Injection is a microbubble ultrasound contrast agent that enhances the visualization of cardiac structures and function.

Patent intelligence

ultrasound contrast agent patent landscape — aggregated cliff calendar, attackable patents, originator estates